Search Results - "Iwazaki, S."

Refine Results
  1. 1
  2. 2
  3. 3

    Adjuvant immunochemotherapy with oral Tegafur Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study by OHWADA, S, LKEYA, T, KAWATE, S, NAKAJIMA, T, MORISHITA, Y, YOKOMORI, T, KUSABA, T, ROPPONGI, T, TAKAHASHI, T, NAKAMURA, S, KAKINUMA, S, IWAZAKI, S, ISHIKAWA, H

    Published in British journal of cancer (08-03-2004)
    “…Intravenous fluorouracil and leucovorin is the standard adjuvant treatment for stage III colon cancer. However, oral adjuvant chemotherapy is attractive…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs by Iwazaki, S, Takeyoshi, I, Ohwada, S, Sunose, Y, Tsutsumi, H, Kawashima, Y, Matsumoto, K, Morishita, Y

    Published in Hepato-gastroenterology (01-01-2001)
    “…Platelet-activating factor is one of the most potent phospholipid mediators associated with inflammatory conditions such as ischemia and reperfusion injury…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Double cancer in different hepatic lobes: hepatocellular and cholangiocellular carcinoma by Ohwada, S, Yoshihiro, O, Iwazaki, S, Tanahashi, Y, Sawada, T, Takeyoshi, I, Kawashima, Y, Nakaura, S, Iino, Y, Morishita, Y

    Published in Hepato-gastroenterology (01-07-1995)
    “…Hepatic tumors with elements of both hepatocellular and cholangiocellular carcinoma are occasionally encountered; however, the independent and simultaneous…”
    Get more information
    Journal Article
  14. 14

    A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer by Takeyoshi, I., Makita, F., Tanahashi, Y., Iwazaki, S., Nakamura, S., Ishikawa, H., Ogawa, T., Ohya, T., Kawate, S., Horiguchi, J., Morishita, Y.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 4593 Background: Paclitaxel and doxifluridine (5’-DFUR; an intermediate metabolite of capecitabine), which have distinct mechanisms of action and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Results of duct-to-mucosa pancreaticojejunostomy for pancreaticoduodenectomy billroth I type reconstruction in 100 consecutive patients by Ohwada, Susumu, Ogawa, Tetsushi, Kawate, Susumu, Tanahashi, Yoshifumi, Iwazaki, Shigeru, Tomizawa, Naoki, Yamada, Takayuki, Ohya, Toshihiro, Morishita, Yasuo

    “…BACKGROUND: This study retrospectively analyzed 100 consecutive patients who underwent pancreaticoduodenectomy (PD) and pylorus-preserving PD (PPPD) with a…”
    Get full text
    Journal Article
  17. 17

    The Effect of a Selective Cyclooxygenase-2 Inhibitor in Extended Liver Resection with Ischemia in Dogs by Takeyoshi, Izumi, Sunose, Yutaka, Iwazaki, Shigeru, Tsutsumi, Hirofumi, Aiba, Masaaki, Kasahara, Mureo, Ohwada, Susumu, Matsumoto, Koshi, Morishita, Yasuo

    Published in The Journal of surgical research (01-09-2001)
    “…Background. Pringle's procedure is commonly used during liver surgery, and it sometimes causes liver failure. Metabolites of arachidonic acid, which are…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    The effect of FR167653 in a canine total hepatic vascular exclusion model by Sunose, Yutaka, Takeyoshi, Izumi, Tsutsumi, Hirofumi, Kawata, Kiyoshi, Iwazaki, Shigeru, Matsumoto, Koshi, Ohwada, Susumu, Morishita, Yasuo

    Published in Hepato-gastroenterology (01-01-2003)
    “…Though liver grafts from non-heart-beating donors are now attracting much attention, these grafts inevitably suffer from severe warm ischemia. The aim of this…”
    Get more information
    Journal Article